Delivery Order SPE2DB25D3018-SPE2DB25FUYNS
- Not listed
- The Defense Logistics Agency awarded a $1,619.84 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units). This firm fixed-price contract, with an ultimate completion date of August 20, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made without...
- The Defense Logistics Agency awarded a delivery order valued at $13,633.82 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on April 24, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a $1,179.55 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 19, 2025, with a completion date of August 20, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award carries no set-aside designation, indicating it...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,501.50 for Trulicity 3 mg/0.5 mL pens on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,501.50 delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on August 26, 2025, with completion scheduled for August 27, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,501.50 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens with an ultimate completion date of August 5, 2025. This non-set-aside contract employs firm fixed price terms and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $1,644.14 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 17, 2025. This competitively awarded, firm fixed-price delivery order is set to be completed by July 18, 2025, with the product to be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $1,801.80 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 7, 2025, with completion scheduled for August 8, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award involved no set-aside designation and was competitively awarded through open...
- The Defense Logistics Agency awarded a $5,377.02 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml dose). This firm fixed price, non-set-aside contract is scheduled for completion by August 13, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,535.16 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on August 22, 2025, with completion targeted for August 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUYNSDelivery Order
The Defense Logistics Agency awarded a $11,982.51 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens under a firm fixed price contract. This delivery order, which is non-set-aside and competitively awarded, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025. Trulicity is a diabetes medication widely used throughout the military healthcare system to support treatment of type 2 diabetes among service members and beneficiaries. This delivery order is part of AmerisourceBergen's comprehensive pharmaceutical supply arrangement with the Defense Logistics Agency, supported by the company's $999,999,999.00 Pharmaceutical Prime Vendor Global Program contract running through December 2026. AmerisourceBergen serves as a critical pharmaceutical distributor for military and veteran healthcare systems, supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As the prime contractor on this arrangement, the company demonstrates substantial capability in fulfilling federal medical procurement requirements through open competition, serving various federal customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 9/17/25 |